1-115725557-GAAAAAAAAAAAAAAA-GAAAAAAAAAAAAAAAA
Variant names:
Variant summary
Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_001232.4(CASQ2):c.738-5dupT variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.052 ( 319 hom., cov: 0)
Exomes 𝑓: 0.035 ( 79 hom. )
Consequence
CASQ2
NM_001232.4 splice_region, intron
NM_001232.4 splice_region, intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.516
Publications
3 publications found
Genes affected
CASQ2 (HGNC:1513): (calsequestrin 2) The protein encoded by this gene specifies the cardiac muscle family member of the calsequestrin family. Calsequestrin is localized to the sarcoplasmic reticulum in cardiac and slow skeletal muscle cells. The protein is a calcium binding protein that stores calcium for muscle function. Mutations in this gene cause stress-induced polymorphic ventricular tachycardia, also referred to as catecholaminergic polymorphic ventricular tachycardia 2 (CPVT2), a disease characterized by bidirectional ventricular tachycardia that may lead to cardiac arrest. [provided by RefSeq, Jul 2008]
CASQ2 Gene-Disease associations (from GenCC):
- catecholaminergic polymorphic ventricular tachycardiaInheritance: AD, AR Classification: DEFINITIVE, MODERATE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- catecholaminergic polymorphic ventricular tachycardia 2Inheritance: AR, AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P, Genomics England PanelApp
- hypertrophic cardiomyopathyInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -16 ACMG points.
BP6
Variant 1-115725557-G-GA is Benign according to our data. Variant chr1-115725557-G-GA is described in CliVar as Benign. Clinvar id is 915585.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-115725557-G-GA is described in CliVar as Benign. Clinvar id is 915585.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-115725557-G-GA is described in CliVar as Benign. Clinvar id is 915585.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-115725557-G-GA is described in CliVar as Benign. Clinvar id is 915585.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-115725557-G-GA is described in CliVar as Benign. Clinvar id is 915585.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-115725557-G-GA is described in CliVar as Benign. Clinvar id is 915585.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-115725557-G-GA is described in CliVar as Benign. Clinvar id is 915585.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.142 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0521 AC: 5925AN: 113780Hom.: 319 Cov.: 0 show subpopulations
GnomAD3 genomes
AF:
AC:
5925
AN:
113780
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0349 AC: 44129AN: 1264726Hom.: 79 Cov.: 0 AF XY: 0.0348 AC XY: 21900AN XY: 629560 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
GnomAD4 exome
AF:
AC:
44129
AN:
1264726
Hom.:
Cov.:
0
AF XY:
AC XY:
21900
AN XY:
629560
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
AC:
2159
AN:
27440
American (AMR)
AF:
AC:
2252
AN:
30604
Ashkenazi Jewish (ASJ)
AF:
AC:
1055
AN:
22194
East Asian (EAS)
AF:
AC:
1447
AN:
35358
South Asian (SAS)
AF:
AC:
3256
AN:
70294
European-Finnish (FIN)
AF:
AC:
1374
AN:
36218
Middle Eastern (MID)
AF:
AC:
87
AN:
3636
European-Non Finnish (NFE)
AF:
AC:
30645
AN:
986638
Other (OTH)
AF:
AC:
1854
AN:
52344
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.310
Heterozygous variant carriers
0
2961
5922
8883
11844
14805
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
1276
2552
3828
5104
6380
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0521 AC: 5930AN: 113752Hom.: 319 Cov.: 0 AF XY: 0.0541 AC XY: 2854AN XY: 52764 show subpopulations
GnomAD4 genome
AF:
AC:
5930
AN:
113752
Hom.:
Cov.:
0
AF XY:
AC XY:
2854
AN XY:
52764
show subpopulations
African (AFR)
AF:
AC:
4466
AN:
30700
American (AMR)
AF:
AC:
925
AN:
10264
Ashkenazi Jewish (ASJ)
AF:
AC:
2
AN:
2990
East Asian (EAS)
AF:
AC:
244
AN:
3800
South Asian (SAS)
AF:
AC:
22
AN:
3260
European-Finnish (FIN)
AF:
AC:
63
AN:
3524
Middle Eastern (MID)
AF:
AC:
0
AN:
224
European-Non Finnish (NFE)
AF:
AC:
147
AN:
56676
Other (OTH)
AF:
AC:
61
AN:
1546
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
241
482
724
965
1206
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
68
136
204
272
340
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
ClinVar
Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Feb 16, 2025
Laboratory of Genetics, Children's Clinical University Hospital Latvia
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Cardiomyopathy Benign:1
Nov 26, 2019
CHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern Ontario
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Catecholaminergic polymorphic ventricular tachycardia 2 Benign:1
Apr 11, 2023
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Catecholaminergic polymorphic ventricular tachycardia 1;C2677794:Catecholaminergic polymorphic ventricular tachycardia 2 Benign:1
Sep 17, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
Aug 13, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.